# Plain Language Summary: Preserving Patient Access to Home Infusion Act

This bill protects patients' ability to receive medical treatments at home through infusion therapy—a process where medications or nutrients are delivered directly into the bloodstream through a tube. The bill ensures that insurance companies and Medicare cannot unfairly restrict or deny coverage for home infusion services, which allow people with chronic illnesses, cancer, infections, or other serious conditions to receive ongoing treatment in the comfort of their own homes instead of having to go to a hospital or clinic repeatedly.

Home infusion therapy is often more convenient and less expensive than hospital-based treatment, and many patients prefer it because they can stay in their familiar environment while recovering. However, insurance companies sometimes try to limit these services by requiring patients to use only certain providers, making it harder to access, or denying coverage altogether. This bill prevents those kinds of restrictions and ensures that patients have genuine choices about where and how they receive their infusion treatments. It also protects the network of home infusion providers—the specialized companies and healthcare workers who deliver these services—from being squeezed out by insurance company policies that make it impossible for them to operate profitably.

The practical effect is that patients who need regular infusions for conditions like hemophilia, immune deficiencies, certain cancers, or chronic infections will have more reliable access to home-based care. They won't face unexpected denials or be forced to travel to medical facilities when they could safely receive treatment at home. For families, this means less disruption to work and daily life, and for the healthcare system overall, it can reduce costs by keeping people out of hospitals and emergency rooms.